RESULTS
214 patients, 107 in the TMX group and 107 in the HRT group (GnRH agonist and
estradiol valerate) were included initially in the study. Nine patients were
excluded from the study due to not meeting inclusion criteria and lost to follow-up
(5 in the TMX and 4 in the HRT group). In addition, 19 participants (13 in the TMX
and 6 in the HRT groups) were taken off treatment due to insufficient endometrial
thickness and pattern; and finally, 11 patients because of lack of embryo viability
during thawing were excluded (5 from each group). Eventually, 176 participants
completed the treatment and entered our analysis (
CONSORT flow diagram of the study.The mean age of patients in the TMX group was 31.07±5.66 years and in the HRT
group was 29.95±4.99 years (Comparison of demographic and hormonal characteristics of study groups. Chi-square test Mann-Whitney testComparison of cycles and pregnancy outcomes between groups. Chi-square test b, Independent Samples Test